Merus Announces Second Quarter 2016 Financial Results and Reviews Recent Clinical Progress and Corporate Developments

Go back to Merus Announces Second Quarter 2016 Financial Results and Reviews Recent Clinical Progress and Corporate Developments

Merus N.V. (MRUS) Reports Q2 Loss of EUR0.40/Share

August 8, 2016 7:11 AM EDT

Merus N.V. (NASDAQ: MRUS) reported Q2 EPS of (EUR0.40), versus (EUR1.25) reported last year. Revenue for the quarter came in at EUR1.1 million, versus EUR1.2 million reported last year.

For earnings history and earnings-related data on Merus N.V. (MRUS) click here.

... More